跳至主要内容
临床试验/ISRCTN71781827
ISRCTN71781827进行中(未招募)未知

Personalised treatment packages for adults with learning disabilities who display aggression in community settings: A cluster randomised controlled trial (PETAL therapy)

Camden and Islington NHS Foundation Trust0 个研究点目标入组 410 人开始时间: 2022年11月16日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
410

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 09/06/2023:
  • 1. Aged 18 years or over
  • 2. Living in the community (e.g., residential care home, supported living, family home)
  • 3. Registered with and/or eligible to receive support from community learning disabilities services
  • 4. Incidents of physical aggression to people or property for at least 3 months. It is likely that people will have several additional comorbid behaviours such as verbal aggression, mental health problems, self-injury, stereotypies etc.
  • 5. Consent to participate provided in keeping with UK capacity legislation or assent from family/nominated consultees for those lacking capacity
  • 6. Family carer/other member able to understand English
  • Previous inclusion criteria:
  • 1. Aged 18 years old and over living in the community
  • 2. Being under the care of a community intellectual disability service
  • 3. Having a diagnosis of intellectual disability diagnosis by community intellectual disability service
  • 4. Weekly incidents of physical aggression to people or property over 3 months
  • 5. Consent to participate provided in keeping with UK capacity legislation or assent from their family/nominated consultees for those lacking capacity
  • 6. Family carer able to understand English or questionnaire version available in the participant’s language.

排除标准

  • Current exclusion criteria as of 09/06/2023:
  • 1. Currently being an inpatient
  • 2. Alcohol or drug dependent
  • 3. Current enrolment in another clinical trial
  • Previous exclusion criteria:
  • 1. Not having an intellectual disability diagnosis
  • 2. Alcohol or drug dependent
  • 3. Current enrolment in another clinical trial

研究者

相似试验

进行中(未招募)
不适用
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMMedDRA version: 16.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 100000004861Diabetes Mellitus, Type 2
EUCTR2013-001473-24-DEEli Lilly and Company880
进行中(未招募)
不适用
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMDiabetes Mellitus, Type 2MedDRA version: 17.0Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlSystem Organ Class: 100000004861
EUCTR2013-001473-24-ATEli Lilly and Company880
进行中(未招募)
1 期
An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus - IMPERIUMDiabetes Mellitus, Type 2
EUCTR2013-001473-24-GBEli Lilly and Company880
已完成
不适用
Towards an individualized treatment of patients with disorders of aggression regulation; endophenotypes of aggressive behavior.aggression regulation disorderIntermittent Explosive Disorder10034726
NL-OMON38824niversitair Medisch Centrum Sint Radboud154
已完成
不适用
A lifestyle intervention program for patients with localized prostate cancer - a feasibility studyC61Malignant neoplasm of prostate
DRKS00005795niversität Duisburg-EssenLehrstuhl und Klinik für Naturheilkund und Integrative Medizin, Knappschafts-Krankenhaus,Kliniken Essen-Mitte17
Personalised treatment packages for adults with a... | 临床试验